|
GS136718: susceptibility to lung cancer 20 (Sluc20, Published QTL Chr 8)
|
|
GS186538: GO:0009308 amine metabolic process
|
|
GS204629: GO:1901564 organonitrogen compound metabolic process
|
|
GS135695: directional asymmetry QTL 19 (Daq19, Published QTL Chr 8)
|
|
GS177310: GO:1901360 organic cyclic compound metabolic process
|
|
GS194657: GO:0046906 tetrapyrrole binding
|
|
GS178461: GO:0009987 cellular process
|
|
GS193220: GO:0006082 organic acid metabolic process
|
|
GS209317: GO:0016702 oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
|
GS35420: Cerebellum Gene expression correlates of Zero Maze - Latency to enter an open quadrant in Females & Males BXD
|
|
GS178392: GO:0016054 organic acid catabolic process
|
|
GS182834: GO:0005623 cell
|
|
GS208912: GO:0046700 heterocycle catabolic process
|
|
GS190997: GO:0044281 small molecule metabolic process
|
|
GS192041: GO:0043169 cation binding
|
|
GS197043: GO:0044282 small molecule catabolic process
|
|
GS136618: colon tumor susceptibility 8 (Scc8, Published QTL Chr 8)
|
|
GS178388: GO:0055114 oxidation-reduction process
|
|
GS199635: GO:0005622 intracellular
|
|
GS136548: proteinuria 1 (Ptnu1, Published QTL Chr 8)
|
|
GS200748: GO:0070189 kynurenine metabolic process
|
|
GS193268: GO:0005575 cellular_component
|
|
GS207365: GO:0005829 cytosol
|
|
GS194039: GO:1901363 heterocyclic compound binding
|
|
GS188190: GO:0006807 nitrogen compound metabolic process
|
|
GS202466: GO:0042402 cellular biogenic amine catabolic process
|
|
GS196943: GO:0008152 metabolic process
|
|
GS136438: platelet-binding antibody-associated thrombocytopenia 2 (Pbat2, Published QTL Chr 8)
|
|
GS183029: GO:0009072 aromatic amino acid family metabolic process
|
|
GS196941: GO:0008150 biological_process
|
|
GS181962: GO:0016491 oxidoreductase activity
|
|
GS191019: GO:0034641 cellular nitrogen compound metabolic process
|
|
GS196491: GO:0004833 tryptophan 2,3-dioxygenase activity
|
|
GS199634: GO:0005623 cell
|
|
GS191842: GO:0006569 tryptophan catabolic process
|
|
GS202188: GO:0044248 cellular catabolic process
|
|
GS196417: GO:0046218 indolalkylamine catabolic process
|
|
GS208781: GO:0006568 tryptophan metabolic process
|
|
GS135294: alcohol withdrawal 6 (Alcw6, Published QTL Chr 8)
|
|
GS183024: GO:0009074 aromatic amino acid family catabolic process
|
|
GS204630: GO:1901565 organonitrogen compound catabolic process
|
|
GS185724: GO:0043436 oxoacid metabolic process
|
|
GS207692: GO:0009310 amine catabolic process
|
|
GS34008: Cerebellum Gene expression correlates of Open Field locomotion 15-30 min post cocaine in Males BXD
|
|
GS201023: GO:0071704 organic substance metabolic process
|
|
GS195214: GO:0009987 cellular process
|
|
GS198211: GO:0006586 indolalkylamine metabolic process
|
|
GS195142: GO:0016054 organic acid catabolic process
|
|
GS136499: proteoglycan induced arthritis 4 (Pgia4, Published QTL Chr 8)
|
|
GS181666: GO:0019439 aromatic compound catabolic process
|
|
GS182683: GO:0020037 heme binding
|
|
GS191106: GO:0044464 cell part
|
|
GS177404: GO:0005737 cytoplasm
|
|
GS195494: GO:0006520 cellular amino acid metabolic process
|
|
GS197244: GO:0044237 cellular metabolic process
|
|
GS201251: GO:0044424 intracellular part
|
|
GS203642: GO:0006725 cellular aromatic compound metabolic process
|
|
GS198755: GO:0016491 oxidoreductase activity
|
|
GS208780: GO:0006569 tryptophan catabolic process
|
|
GS193718: GO:0044106 cellular amine metabolic process
|
|
GS207923: GO:0034641 cellular nitrogen compound metabolic process
|
|
GS187462: GO:0019752 carboxylic acid metabolic process
|
|
GS181533: GO:0046872 metal ion binding
|
|
GS185634: GO:0042402 cellular biogenic amine catabolic process
|
|
GS199826: GO:0009074 aromatic amino acid family catabolic process
|
|
GS136340: nicotine induced locomotor activity 5 (Nilac5, Published QTL Chr 8)
|
|
GS198263: GO:0005488 binding
|
|
GS194040: GO:1901360 organic cyclic compound metabolic process
|
|
GS128577: Ethanol induced LORR Chr# 8
|
|
GS191843: GO:0006568 tryptophan metabolic process
|
|
GS185827: GO:0051213 dioxygenase activity
|
|
GS84203: chronic alcohol withdrawal severity (Published QTL, Chr 8)
|
|
GS183585: GO:0046395 carboxylic acid catabolic process
|
|
GS199478: GO:0020037 heme binding
|
|
GS210666: GO:0044106 cellular amine metabolic process
|
|
GS177311: GO:1901361 organic cyclic compound catabolic process
|
|
GS187517: GO:0006576 cellular biogenic amine metabolic process
|
|
GS198323: GO:0046872 metal ion binding
|
|
GS204326: GO:0019752 carboxylic acid metabolic process
|
|
GS34027: Cerebellum Gene expression correlates of Open Field locomotion 45-60 min post cocaine in Males BXD
|
|
GS184447: GO:0044424 intracellular part
|
|
GS34057: Cerebellum Gene expression correlates of Open Field locomotion (cm) 45-60 min post cocaine in Males BXD
|
|
GS136323: non-heme iron levels 4 (Nhil4, Published QTL Chr 8)
|
|
GS207862: GO:0009056 catabolic process
|
|
GS198455: GO:0019439 aromatic compound catabolic process
|
|
GS205047: GO:0006807 nitrogen compound metabolic process
|
|
GS180452: GO:0044237 cellular metabolic process
|
|
GS202555: GO:0043436 oxoacid metabolic process
|
|
GS135756: experimental allergic encephalomyelitis susceptibility 24 (Eae24, Published QTL Chr 8)
|
|
GS193321: GO:0033754 indoleamine 2,3-dioxygenase activity
|
|
GS187770: GO:1901565 organonitrogen compound catabolic process
|
|
GS192074: GO:1901575 organic substance catabolic process
|
|
GS135748: experimental allergic encephalomyelitis susceptibility 14 (Eae14, Published QTL Chr 8)
|
|
GS203443: GO:0019441 tryptophan catabolic process to kynurenine
|
|
GS180164: GO:0008150 biological_process
|
|
GS178736: GO:0006520 cellular amino acid metabolic process
|
|
GS202597: GO:0042430 indole-containing compound metabolic process
|
|
GS135319: alcohol preference 8 QTL (Ap8q, Published QTL Chr 8)
|
|
GS136097: long bones 7 (Lbn7, Published QTL Chr 8)
|
|
GS136201: lung tumor shape-determining 3 (Ltsd3, Published QTL Chr 8)
|
|
GS185585: GO:0044710 single-organism metabolic process
|
|
GS136555: protection against vaginal candidiasis 1 (Pvcan1, Published QTL Chr 8)
|
|
GS136240: macrophage-associated risk inflammatory factor 2 (Marif2, Published QTL Chr 8)
|
|
GS205255: GO:0044238 primary metabolic process
|
|
GS185584: GO:0044712 single-organism catabolic process
|
|
GS210263: GO:0033754 indoleamine 2,3-dioxygenase activity
|
|
GS187769: GO:1901564 organonitrogen compound metabolic process
|
|
GS199831: GO:0009072 aromatic amino acid family metabolic process
|
|
GS181422: GO:0006586 indolalkylamine metabolic process
|
|
GS186596: GO:0019441 tryptophan catabolic process to kynurenine
|
|
GS208012: GO:0044464 cell part
|
|
GS185366: GO:0044248 cellular catabolic process
|
|
GS194041: GO:1901361 organic cyclic compound catabolic process
|
|
GS210212: GO:0005575 cellular_component
|
|
GS135559: CD8 T cell subset 2 (Cd8ts2, Published QTL Chr 8)
|
|
GS201239: GO:0046483 heterocycle metabolic process
|
|
GS208978: GO:0043169 cation binding
|
|
GS200384: GO:0046395 carboxylic acid catabolic process
|
|
GS210163: GO:0006082 organic acid metabolic process
|
|
GS188399: GO:0044238 primary metabolic process
|
|
GS84202: METH responses for home cage activity (Published QTL, Chr 8)
|
|
GS190954: GO:0009056 catabolic process
|
|
GS135958: HDL QTL 25 (Hdlq25, Published QTL Chr 8)
|
|
GS209455: GO:0003824 catalytic activity
|
|
GS184218: GO:0071704 organic substance metabolic process
|
|
GS201002: GO:0044270 cellular nitrogen compound catabolic process
|
|
GS184435: GO:0046483 heterocycle metabolic process
|
|
GS204132: GO:0009063 cellular amino acid catabolic process
|
|
GS202414: GO:0044712 single-organism catabolic process
|
|
GS192384: GO:0016701 oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
|
GS187516: GO:0006575 cellular modified amino acid metabolic process
|
|
GS203381: GO:0009308 amine metabolic process
|
|
GS185761: GO:0042436 indole-containing compound catabolic process
|
|
GS202593: GO:0042436 indole-containing compound catabolic process
|
|
GS210002: GO:0044444 cytoplasmic part
|
|
GS179657: GO:0046218 indolalkylamine catabolic process
|
|
GS177913: GO:0046906 tetrapyrrole binding
|
|
GS135352: Alzheimer's disease modifier 4 (Azdm4, Published QTL Chr 8)
|
|
GS182835: GO:0005622 intracellular
|
|
GS184198: GO:0044270 cellular nitrogen compound catabolic process
|
|
GS202415: GO:0044710 single-organism metabolic process
|
|
GS191973: GO:0046700 heterocycle catabolic process
|
|
GS35736: Cerebellum Gene expression correlates of Open Field locomotion (cm) 0-15 min post cocaine in Males BXD
|
|
GS207903: GO:0044281 small molecule metabolic process
|
|
GS194087: GO:0003674 molecular_function
|
|
GS194133: GO:0005737 cytoplasm
|
|
GS186790: GO:0006725 cellular aromatic compound metabolic process
|
|
GS177356: GO:0003674 molecular_function
|
|
GS34325: Cerebellum Gene expression correlates of Cocaine TOTAL locomotion (activity beam breaks) in Males BXD
|
|
GS204383: GO:0006575 cellular modified amino acid metabolic process
|
|
GS185765: GO:0042430 indole-containing compound metabolic process
|
|
GS194111: GO:0097159 organic cyclic compound binding
|
|
GS189860: GO:0043167 ion binding
|
|
GS177309: GO:1901363 heterocyclic compound binding
|
|
GS180264: GO:0044282 small molecule catabolic process
|
|
GS180166: GO:0008152 metabolic process
|
|
GS183950: GO:0070189 kynurenine metabolic process
|
|
GS35721: Cerebellum Gene expression correlates of Open Field locomotion 0-15 min post cocaine in Males BXD
|
|
GS206742: GO:0043167 ion binding
|
|
GS136374: obesity QTL 20 (Obq20, Published QTL Chr 8)
|
|
GS84200: nicotine sensitivity (Published QTL, Chr 8)
|
|
GS177382: GO:0097159 organic cyclic compound binding
|
|
GS204384: GO:0006576 cellular biogenic amine metabolic process
|
|
GS192382: GO:0016702 oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
|
GS135859: femur breaking strength 2 (Fembrs2, Published QTL Chr 8)
|
|
GS209010: GO:1901575 organic substance catabolic process
|
|
GS126584: Tetrachlorodibenzodioxin interacting genes (MeSH:D013749) in CTD
|
|
GS136138: lithogenic gene 19 (Lith19, Published QTL Chr 8)
|
|
GS187274: GO:0009063 cellular amino acid catabolic process
|
|
GS181473: GO:0005488 binding
|
|
GS202664: GO:0051213 dioxygenase activity
|
|
GS135385: body weight (Bdywt, Published QTL Chr 8)
|
|
GS209319: GO:0016701 oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
|
GS190788: GO:0009310 amine catabolic process
|
|
GS192512: GO:0003824 catalytic activity
|
|
GS34017: Cerebellum Gene expression correlates of Open Field locomotion 30-45 min post cocaine in Males BXD
|